Pharma stocks are under significant selling pressure. Here is a detailed analysis on the top worries for the sector.

The Nifty Pharma index closed on a negative note on Wednesday. Shares of Mankind Pharma Ltd.(up 0.24 per cent), Biocon ...

The broader market continued displaying mixed trends with the Nifty Midcap 100 gaining 0.2 percent and Smallcap 100 falling 0 ...

As much as $135 million in value will be unlocked as stock of five companies eligible for trading as their shareholder ...

Global private equity major KKR is set to trim its holdings in JB Chemicals & Pharmaceuticals Ltd, offloading a 6.8% stake ...

The issue of drug pricing violations has come under scrutiny, with the Parliamentary Standing Committee on Chemicals and ...

India could potentially lose $6 billion or 0.16 per cent GDP in exports to the US at 10 per cent broad tariffs, with this ...

Violations highlight growing concerns over the unchecked rise in medicine prices and their impact on affordability ...

Experts underestimated Trump's seriousness on tariffs; Indian auto and pharma sectors brace for impact, while steel remains ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...